Search Results - "Coe, Kelci"
-
1
S230 Risk Factors for Fecal Microbiota Transplant Failure and Their Utility in Predicting FMT Outcomes: A Nationwide Retrospective Study
Published in The American journal of gastroenterology (01-10-2023)“…A forward selection method was conducted, which took into consideration adjusted R2, AIC, and the log-likelihood to determine the best model fit. In the final…”
Get full text
Journal Article -
2
Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
Published in Journal of antimicrobial chemotherapy (01-07-2019)“…Abstract Background Stenotrophomonas maltophilia is intrinsically resistant to several antibiotics, making it potentially challenging to treat. Studies have…”
Get full text
Journal Article -
3
Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients
Published in Supportive care in cancer (01-09-2021)“…Purpose Bloodstream infections (BSI) are significant causes of morbidity and mortality in cancer patients. These patients often receive 10 to 14 days of…”
Get full text
Journal Article -
4
Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem
Published in International journal of antimicrobial agents (01-12-2019)“…Enterobacter spp. are a common cause of nosocomial pneumonia and treatment can be complicated by AmpC resistance. Carbapenems are the treatment of choice;…”
Get full text
Journal Article -
5
Effectiveness of short vs long‐course perioperative antibiotics in lung transplant recipients with donor positive respiratory cultures
Published in Transplant infectious disease (01-06-2021)“…Lung transplant recipients are at increased risk for infection in the early postoperative phase, thus perioperative antibiotics are employed. This…”
Get full text
Journal Article -
6
Clinical Outcomes with Penicillin Versus Alternative β‐Lactams in the Treatment of Penicillin‐Susceptible Staphylococcus aureus Bacteremia
Published in Pharmacotherapy (01-07-2018)“…Objectives To identify the impact of penicillin versus alternative β‐lactams on clinical outcomes in patients with penicillin‐susceptible Staphylococcus aureus…”
Get full text
Journal Article -
7
Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline
Published in Open forum infectious diseases (01-07-2021)“…Abstract Background Lower mortality has been observed with combination therapy compared to monotherapy for methicillin-resistant Staphylococcus aureus (MRSA)…”
Get full text
Journal Article -
8
Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients
Published in Diagnostic microbiology and infectious disease (01-01-2022)“…The primary objectives were to determine the prevalence of and identify variables associated with respiratory bacterial co-infection in COVID-19 inpatients…”
Get full text
Journal Article -
9
Clinical outcomes of combination versus monotherapy for gram negative non-HACEK infective endocarditis
Published in Diagnostic microbiology and infectious disease (01-11-2021)“…•Non-HACEK Gram negative endocarditis is associated with high mortality•More than one agent is recommended to treat non-HACEK Gram negative…”
Get full text
Journal Article -
10
Speed, Spectrum, and Satisfaction: Assessment of an Infectious Diseases eConsult Program
Published in Open forum infectious diseases (01-05-2024)“…This report examines the implementation and early functioning of a new infectious diseases (ID) eConsult program. We recorded the reasons for placing ID…”
Get full text
Journal Article -
11
Clinical Outcomes with Ertapenem for Pneumonia in Obese versus Nonobese Patients
Published in Antimicrobial agents and chemotherapy (18-01-2022)“…The objective of this study was to compare the rate of pneumonia resolution in obese (body mass index [BMI], ≥30 kg/m ) and nonobese (BMI, <30 kg/m ) patients…”
Get full text
Journal Article -
12
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk
Published in Pharmacotherapy (01-12-2022)“…Study Objective The aim of this study was to evaluate the effect on bleeding risk when fluconazole is administered concomitantly with direct oral…”
Get full text
Journal Article -
13
Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results
Published in Journal of clinical microbiology (23-04-2020)“…infection (CDI) is one of the most common health care-associated infections that can cause significant morbidity and mortality. CDI diagnosis involves…”
Get full text
Journal Article -
14
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections
Published in International journal of antimicrobial agents (01-08-2021)“…•Staphylococcus aureus is a leading cause of bacteraemia and endocarditis worldwide•The preferred therapy for Staphylococcus aureus bacteraemia is an…”
Get full text
Journal Article -
15
Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile
Published in Journal of clinical pharmacy and therapeutics (01-08-2021)“…What is Known and Objective The 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridioides difficile infection (CDI) recommend treating recurrent episodes…”
Get full text
Journal Article -
16
272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
Published in Open forum infectious diseases (31-12-2020)“…Abstract Background Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with increased morbidity and mortality. Previous…”
Get full text
Journal Article -
17
599. Association between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
Published in Open forum infectious diseases (15-12-2022)“…Abstract Background Vancomycin (VAN) is an efficacious therapy against Streptococcus. VAN area under the curve to minimum inhibitory concentration (AUC/MIC) is…”
Get full text
Journal Article -
18
Association Between Vancomycin AUC and Clinical Failure in Patients with Streptococcal Bacteremia
Published in Hospital pharmacy (Philadelphia) (01-06-2023)“…Background: Monitoring of vancomycin using the area under the curve (AUC) to minimum inhibitory concentration (MIC) ratio is now preferred for serious…”
Get full text
Journal Article -
19
600. The Effect of Medication-Assisted Treatment on Completion Rates of Outpatient Parenteral Antibiotic Therapy
Published in Open forum infectious diseases (04-12-2021)“…Abstract Background Injection drug use is a nationwide epidemic associated with an increased risk of invasive Staphylococcus aureus (S. aureus) infections…”
Get full text
Journal Article -
20
307. Predictors of Respiratory Bacterial Co-Infection in Hospitalized COVID-19 Patients
Published in Open forum infectious diseases (04-12-2021)“…Abstract Background COVID-19 pneumonia can be indistinguishable from other infectious respiratory etiologies, so providers are challenged with deciding whether…”
Get full text
Journal Article